Press Releases Pear Therapeutics, Inc.

Equities

PEARQ

US7047231052

Market Closed - OTC Markets Other stock markets 10:03:36 2024-03-22 am EDT			5-day change	1st Jan Change
0.000001 ^USD	-99.00%		-.--%	-.--%

Mar. 22	Disclosure Statement and Plan Approved on Interim Basis for Pear Therapeutics, Inc.	CI
Mar. 04	Combined Liquidation Plan and Disclosure Statement Filed by Pear Therapeutics, Inc.	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PEAR THERAPEUTICS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	23-04-10	AQ
PEAR THERAPEUTICS FILES FOR CHAPTER 11 AND WILL SEEK TO SELL ASSETS THROUGH SALES PROCESS	23-04-10	AQ
PEAR THERAPEUTICS, INC. : Termination of a Material Definitive Agreement, Bankruptcy or Receivership, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Costs Associated with Exit or Disposal Activities, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-04-07	AQ
Pear Therapeutics Files for Chapter 11 and Will Seek to Sell Assets Through Sales Process	23-04-07	BU
PEAR THERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	23-03-31	AQ
PEAR THERAPEUTICS ANNOUNCES PROCESS EXPLORING STRATEGIC ALTERNATIVES	23-03-20	AQ
PEAR THERAPEUTICS, INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-03-17	AQ
Pear Therapeutics Announces Process Exploring Strategic Alternatives	23-03-17	BU
Pear Therapeutics to Participate in 43rd Annual Cowen Healthcare Conference	23-02-27	BU
PEAR THERAPEUTICS, INC. : Change in Directors or Principal Officers, Other Events (form 8-K)	23-02-24	AQ
Pear Therapeutics to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference	23-02-02	BU
Pear Therapeutics and BrightView Health Expand Pilot Program to Provide Prescription Digital Therapeutics for the Treatment of Substance Use Disorders	23-01-26	BU
PEAR THERAPEUTICS ANNOUNCES INCLUSION OF RESET AND RESET-O ON THE JANUARY 2023 FLORIDA MEDICAID PREFERRED DRUG LIST	23-01-19	AQ
Pear Therapeutics to Participate in Citi's BioTech C-Suite Virtual Fireside Chat Series	23-01-18	AQ
Pear Therapeutics Announces Inclusion of reSET® and reSET-O® on the January 2023 Florida Medicaid Preferred Drug List	23-01-18	BU
Pear Therapeutics to Participate in Citi’s BioTech C-Suite Virtual Fireside Chat Series	23-01-17	BU
California Department of Health Care Services Awards Contract to Pear Therapeutics to Support the Recovery Incentives Program	23-01-12	BU
Pear Therapeutics and COEUS Healthcare Partner to Combat the Addiction Crisis With Prescription Digital Therapeutics	23-01-10	BU
Pear Therapeutics and Spero Health to Expand Access to Prescription Digital Therapeutics for People in Recovery Across Multiple Locations and States	23-01-04	BU
PEAR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	23-01-03	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Pear Therapeutics, Inc.

Equities

PEARQ

US7047231052

Press Releases

Filters